Faith L. Charles - 30 Dec 2022 Form 4 Insider Report for CNS Pharmaceuticals, Inc. (CNSP)

Role
Director
Signature
/s/ Christopher Downs, Attorney-in-fact
Issuer symbol
CNSP
Transactions as of
30 Dec 2022
Net transactions value
$0
Form type
4
Filing time
04 Jan 2023, 15:02:23 UTC
Previous filing
28 Sep 2022
Next filing
16 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNSP Option to purchase common stock Award +3,500 3,500 30 Dec 2022 Common Stock 3,500 $2.40 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options set forth in this table vest in 36 equal monthly installments succeeding the issuance date, or December 30, 2022, subject to the grantee's continued service on the Company's Board of Directors on each vesting date.
F2 The options were issued in connection with the reporting person's Board of Director services to the Company.